site stats

Cingulate therapeutics llc

WebCingulate Therapeutics, Kansas City, Kansas. 92 likes · 2 were here. Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage bio-pharmaceutical company foc WebJul 13, 2024 · Should You Buy or Sell Cingulate Stock? Get The Latest CING Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ...

Cingulate: Precision Timed Release ADHD Drug Developer ... - SeekingAlpha

WebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third … 10 Mar 2024 Cingulate Inc. Reports Fourth Quarter and Full Year 2024 Financial … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member … WebSep 23, 2024 · EX-10.7 6 ex10-7.htm . Exhibit 10.7 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … grammy awards 2016 winners https://readysetbathrooms.com

Cingulate - Overview, News & Competitors ZoomInfo.com

WebJan 1, 2024 · EX-10.10 2 ex10-10.htm . Exhibit 10.10 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of January 1, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS 66205 (the … WebShane J. Schaffer founded Cingulate, Inc., Cingulate Works, Inc. and Cingulate Therapeutics LLC. Presently, Dr. Schaffer holds the position of Chairman & Chief Executive Officer for Cingulate, Inc. and Chairman & Chief Executive Officer of Cingulate Therapeutics LLC and Chairman & Chief Executive Officer of Cingulate Works, Inc. … WebSep 23, 2024 · EX-10.4 3 ex10-4.htm . Exhibit 10.4 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … china spring isd administration

Cingulate Therapeutics Kansas City KS - Facebook

Category:Amendment to Employment Agreement, effective January 1, 2024 ...

Tags:Cingulate therapeutics llc

Cingulate therapeutics llc

Home - Cingulate Inc

WebThis Joint Commercialization Agreement (this “Agreement”) is made on March 7 th 2024 (the “Effective Date”) by and between Indegene, Inc., a Delaware corporation having its place of business at Suite 104, 150 College Road W, Princeton, NJ 08540 (hereinafter referred to as “Indegene”) and Cingulate Therapeutics LLC, a Delaware ...

Cingulate therapeutics llc

Did you know?

WebSep 14, 2024 · Prior to the closing of this IPO, the company will affect a “reorganization merger” in which Cingulate Inc. will acquire Cingulate Therapeutics LLC (CTx) through the merger of a wholly-owned ... WebAug 8, 2024 · Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit ...

WebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug … WebFounders Craig Gilgallon, Matthew Brams, Raul Silva, Shane J Schaffer. Operating Status Active. Last Funding Type Venture - Series Unknown. …

WebOct 26, 2024 · Cingulate Therapeutics, LLC is a privately-held, clinical-stage, biopharmaceutical company focused on the development of new and innovative products … WebMay 31, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products …

WebJan 7, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ...

WebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas. china spring isd calendar 2022 2023WebCingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 [email protected]. Legal 6 South Street, Suite 203 Morristown, New Jersey 07960. Clinical Trial Investigators [email protected]. Investor Relations Thomas Dalton Head of Investor & Public Relations (913) 942-2301 china spring isd elementaryWebAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 30, 2024 by and among Cingulate Therapeutics LLC, a Delaware limited liability company (“CTx”), … china spring isd hrWebApr 2, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... china spring isd job listingsWebExhibit 10.1 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of April 1, 2024 by and between CINGULATE THERAPEUTICS … grammy awards 2017WebMar 10, 2024 · Cingulate plans to commence two CTx-1301 Phase 3 clinical studies in 2024: (1) a fixed-dose pediatric and adolescent safety and efficacy study, which will … china spring isd education foundationWebCingulate Therapeutics. Jan 2024 - Present4 years 4 months. Kansas City, Kansas. china spring isd facebook